BE902344A - Produits conjugues d'anthracyclines/polymeres anioniques. - Google Patents

Produits conjugues d'anthracyclines/polymeres anioniques.

Info

Publication number
BE902344A
BE902344A BE0/214956A BE214956A BE902344A BE 902344 A BE902344 A BE 902344A BE 0/214956 A BE0/214956 A BE 0/214956A BE 214956 A BE214956 A BE 214956A BE 902344 A BE902344 A BE 902344A
Authority
BE
Belgium
Prior art keywords
anionic polymer
anthracycline
polymer conjugates
new
products
Prior art date
Application number
BE0/214956A
Other languages
English (en)
Inventor
F Zunino
R A Gambetta
S Penco
Original Assignee
Erba Farmitalia
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia, Ist Naz Stud Cura Dei Tumori filed Critical Erba Farmitalia
Publication of BE902344A publication Critical patent/BE902344A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Nouveaux produits conjugués de doxorubicine et de ses analogues avec un polymère anionique. Le polymère anionique utilisé est un copolymère de pyranne (cyclopolymère 1,2 régulièrement alterné d'éther divinylique et d'anhydride maléique, également connu sous l'appellation 'DVE-MA') sous sa forme polycarboxylate. La liaison des agents antitumeurs au polymère est effectuée par une liaison ester obtenue par substitution nucléophile sur leurs dérivés 14-bromo. Etant donné qu'ils sont libérés lentement 'in vivo', les nouveaux produits conjugués améliorent considérablement le comportement pharmacocinétique et l'efficacité thérapeutique des agents antitumeurs.
BE0/214956A 1984-05-25 1985-05-03 Produits conjugues d'anthracyclines/polymeres anioniques. BE902344A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848413464A GB8413464D0 (en) 1984-05-25 1984-05-25 Anthracycline-anionic polymer conjugates

Publications (1)

Publication Number Publication Date
BE902344A true BE902344A (fr) 1985-09-02

Family

ID=10561522

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214956A BE902344A (fr) 1984-05-25 1985-05-03 Produits conjugues d'anthracyclines/polymeres anioniques.

Country Status (4)

Country Link
JP (1) JPS6156128A (fr)
BE (1) BE902344A (fr)
DE (1) DE3515178A1 (fr)
GB (2) GB8413464D0 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378456A (en) * 1993-03-25 1995-01-03 American Cyanamid Company Antitumor mitoxantrone polymeric compositions
EP0710689A2 (fr) 1994-11-01 1996-05-08 American Cyanamid Company Agents polymères antitumoraux

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0130906B1 (ko) * 1987-03-11 1998-04-23 팜이탈리아 카를로 에르바 에스. 알. 엘. 면역글로불린 결합체, 이의 제조방법 및 이를 포함하는 약제학적 조성물
ATE120647T1 (de) * 1987-05-28 1995-04-15 Hiroshi Maeda Superoxid-dismutase-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel.
IT1230505B (it) * 1988-10-11 1991-10-25 Sicor Spa Procedimento per la conversione della daunorubicina in doxorubicina.
JPH03101616A (ja) * 1989-07-12 1991-04-26 Union Carbide Chem & Plast Co Inc 製薬学的活性誘導体の放出系

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602967A (en) * 1977-07-16 1981-11-18 Hercules Inc Reaction prodcut of methotrexate with divinyl ether and maleic anhydride copolymer

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378456A (en) * 1993-03-25 1995-01-03 American Cyanamid Company Antitumor mitoxantrone polymeric compositions
EP0710689A2 (fr) 1994-11-01 1996-05-08 American Cyanamid Company Agents polymères antitumoraux

Also Published As

Publication number Publication date
GB2158078B (en) 1987-09-16
JPS6156128A (ja) 1986-03-20
GB2158078A (en) 1985-11-06
DE3515178A1 (de) 1985-11-28
GB8413464D0 (en) 1984-07-04
GB8510222D0 (en) 1985-05-30

Similar Documents

Publication Publication Date Title
EP0495265B1 (fr) Linker molécules labiles aux acides
EP0328147A3 (fr) Immunoconjugués d'anthracyclines à spacer et leurs procédés de préparation
US5010176A (en) Antibody-drug conjugates
AU2223988A (en) Modified antibodies for enhanced clearance
JPS61243026A (ja) 重合性薬剤の製造方法
AU2020188A (en) Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
JPH07149666A (ja) プロ−プロドラッグ、その製造および使用
FI902387A0 (fi) Antracyklinkonjugat med en ny linker och foerfaranden foer deras framstaellning.
Duncan N-(2-Hydroxypropyl) methacrylamide copolymer conjugates
CA2101648A1 (fr) Conjugues polysaccharide-proteine
Zunino et al. Poly (carboxylic acid) polymers as carriers for anthracyclines
WO2001074399A1 (fr) Medicaments a long temps de conservation dans un tissu
Takahashi et al. Isolation and hypoglycemic activity of saccharans A, B, C, D, E and F, glycans of Saccharum officinarum stalks1
Říhová et al. Cytotoxic and cytostatic effects of anti-Thy 1.2 targeted doxorubicin and cyclosporin A
KR100249067B1 (ko) 안트라사이클린 결합체 및 이의 제조방법
EP0184838B1 (fr) Conjugués d'adénine-9-bêta-arabinofuranoside-5'-monophosphate et d'albumine humaine lactosaminée, méthode de préparation et compositions thérapeutiquement actives les contenant
GB2158078A (en) Anthracycline-anionic polymer conjugates
CA2190867A1 (fr) Procedes pour l'absorption renale reduite de fragments d'anticorps
OUCHI¹ et al. Design of Macromolecular Prodrug of ADR Using CM-Chitin as a Carrier
Wilchek Affinity Therapy
DUNCAN Centre for Polymer Therapeutics, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
WO1991001757A1 (fr) Couplage d'un anti-tumeur a un anticorps au moyen d'un agent antitumoral pre-active a la glutaraldehyde

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FARMITALIA CARLO ERBA S.P.A.

Effective date: 19880531

Owner name: ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI T

Effective date: 19880531